Earnings Outlook For Evolent Health

Evolent Health EVH releases its next round of earnings this Wednesday, May 05. Here is Benzinga's essential guide to Evolent Health's Q1 earnings report.

What Are Earnings, Net Income, And Earnings Per Share?

Earnings and EPS are useful metrics of profitability. Total earnings also known as net income is equal to total revenue minus total expenses. Dividing net income by the total number of shares outstanding yields EPS.

Earnings And Revenue

Sell-side analysts are expecting Evolent Health's loss per share to be near $0.06 on sales of $212.79 million. Evolent Health's loss in the same period a year ago was $0.14 per share. Quarterly sales came in at $247.28 million.

Why Analyst Estimates And Earnings Surprises Are Important

Wall Street analysts who study this company will publish analyst estimates of revenue and EPS. The averages of all analyst EPS and revenue estimates are called the "consensus estimates"; these consensus estimates can have a significant effect on a company's performance during an earnings release. When a company posts earnings or revenue above or below a consensus estimate, it has posted an "earnings surprise", which can really move a stock depending on the difference between actual and estimated values.

If the company were to match the consensus estimate when it reports Wednesday, earnings would be up 57.14%. Revenue would be down 13.95% from the year-ago period. Evolent Health's reported EPS has stacked up against analyst estimates in the past like this:

Stock Performance

Over the last 52-week period, shares are up 238.63%. Given that these returns are generally positive, long-term shareholders can relax going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.

Do not be surprised to see the stock move on comments made during its conference call. Evolent Health is scheduled to hold the call at 18:00:00 ET and can be accessed here.